TB500 (TB4 / Thymosin Beta-4)
Thymosin beta-4 is studied in wound-healing contexts (preclinical + some clinical programs). 'TB500' in commerce is often loosely used; do not assume equivalence across products.
Stacks containing TB500 (TB4 / Thymosin Beta-4)
Public community stacks that include this ingredient.
Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect and component-based.
Groups the two most commonly paired research peptides discussed in injury-repair circles; evidence is largely preclinical and not athlete-RCT grade.
TB4 accelerated wound healing endpoints in a rat model compared with controls.
A review summarizes phase 2 wound-healing programs reporting faster healing in those that did heal; note that these are not sports injury RCTs.
TB4 gel has been studied in venous stasis ulcer indications; registry evidence supports clinical testing, though effect sizes depend on the specific trial and endpoint reporting.